Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population‐based prospective cohort study-Reference-Cited by-同舟云学术

Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population‐based prospective cohort study

Published:2021-09-05 Issue:12 Volume:19 Page:2984-2996
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Königsbrügge Oliver¹^ORCID,Meisel Hannah¹,Beyer Aljoscha¹,Schmaldienst Sabine²,Klauser‐Braun Renate³,Lorenz Matthias⁴,Auinger Martin⁵,Kletzmayr Josef³,Hecking Manfred⁶,Winkelmayer Wolfgang C.⁷,Lang Irene⁸,Pabinger Ingrid¹,Säemann Marcus⁹,Ay Cihan¹^ORCID

Affiliation:

1. Clinical Division of Hematology and Hemostaseology Department of Medicine I Medical University of Vienna Vienna Austria

2. Department of Medicine I Clinic Favoriten Vienna Austria

3. Department of Medicine III Clinic Donaustadt Vienna Austria

4. Vienna Dialysis Center Vienna Austria

5. Department of Medicine III Clinic Hietzing Vienna Austria

6. Clinical Division of Nephrology Department of Medicine III Medical University of Vienna Vienna Austria

7. Section of Nephrology Department of Medicine Selzman Institute for Kidney Health Baylor College of Medicine Houston USA

8. Division of Cardiology Department of Internal Medicine II Medical University of Vienna Vienna Austria

9. Department of Medicine VI Clinic Ottakring Vienna Austria

Funder

Austrian Science Fund

Oesterreichische Nationalbank

NIH Clinical Center

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15508

Reference46 articles.

1. Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study

2. Elevated risk of stroke among patients with end-stage renal disease

3. Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation

4. Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI)

5. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From arteries to veins: the expanding role of lipid-lowering drugs in preventing thrombosis;European Heart Journal;2024-08-14

2. Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path;Reviews in Cardiovascular Medicine;2024-06-25

3. Anticoagulation in atrial fibrillation and end-stage kidney disease on hemodialysis: a meta-analysis of randomized trials comparing direct oral anticoagulants with vitamin K antagonists;Research and Practice in Thrombosis and Haemostasis;2024-01

4. Outcomes of venous thromboembolism care: future directions;Journal of Thrombosis and Haemostasis;2023-05

5. Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI study;Nephrology Dialysis Transplantation;2022-12-06